RxDoctor Payments Data

Abha Soni, DO

Dermatopathology · Smyrna, GANPI 1689019184

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Galderma Laboratories, L.p. at 41.0% of the total. Reporting peaked in 2019 at $249 and has fallen 88.9% since, to $28 in 2025. That places this record below the midpoint for dermatopathology clinicians in GA, where the typical reported total is $319.

$319in general payments, 2019–2025

Across 5 payments — averaging $63.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$131
  • Stemline Therapeutics Inc.$118
  • Hologic Sales And Service, LLC$56
  • Myriad Genetic Laboratories, Inc.$15

What the payments were for

  • Food & beverage$319100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$319 in reported general payments places this provider in the 50th percentile of 25 dermatopathology providers in Georgia.

See all dermatopathology providers in Georgia

Medicare billing

Part B allowed, 2024
$534,672
Medicare patients
2,584
Services billed
5,175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatopathology in Smyrna

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →